Filing Details

Accession Number:
0001494650-21-000111
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-17 13:57:08
Reporting Period:
2021-09-15
Accepted Time:
2021-09-17 13:57:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1494650 Optinose Inc. OPTN Pharmaceutical Preparations (2834) 421771610
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1718725 A Ramy Mahmoud C/O Optinose, Inc.
1020 Stony Hill Road, Suite 300
Yardley PA 19067
President And Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-09-15 39,754 $0.00 294,264 No 4 M Direct
Common Stock Disposition 2021-09-16 11,588 $2.79 282,676 No 4 S Direct
Common Stock Disposition 2021-09-16 911 $2.79 281,765 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2021-09-15 39,754 $0.00 39,754 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
39,753 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 35,726 Indirect By: The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud
Footnotes
  1. Represents the vesting of a restricted stock units (RSUs) granted on September 15, 2020. 50% of the RSUs subject to this award shall vest on September 15, 2021 and the balance shall vest on September 15, 2022, subject to the reporting person's continuous service through such vesting date.
  2. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted share units granted on September 15, 2020. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
  3. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted share units granted on March 6, 2020. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
  4. RSUs convert into common stock on a one-for-one basis.